Sobi walks away from deal talks
There will be no deal between the Swedish-based biotech group Sobi, in which Danish national Bo Jesper Hansen is Chairman and major shareholder, and the company’s secret suitor.
BY LONNI LYNGE
A few months ago, the biotech company Swedish Orphan Biovitrum AB (Sobi) said it had received a preliminary non-binding proposal in relation to a possible offer for all shares issued by the company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Here is why Topotarget Chairman stepped back
For abonnenter
Medicon Valley Alliance headed for breakup
For abonnenter
Analysts: This is where Novo can stand out
For abonnenter
